To access this element change to forms mode OFF
Grant Award View - GA166532
Oral bacterial lysate to prevent persistent wheeze in infants after...
GA ID:
GA166532
Agency:
Department of Health and Aged Care
Approval Date:
24-Mar-2021
Publish Date:
25-May-2021
Category:
Health and Medical Research
Grant Term:
1-May-2021 to 30-Apr-2026
Value (AUD):
$1,598,380.42
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF ICTC Round 1_2021
Grant Activity:
Oral bacterial lysate to prevent persistent wheeze in infants after severe bronchiolitis; a randomised placebo controlled trial (BLIPA; Bacterial Lysate in Preventing Asthma)
Purpose:
Preventing the development of wheeze in preschool children would produce major health benefits, but to date no therapies have proved to be effective. A group of infants who are at very high risk of developing preschool wheeze and subsequent asthma, are infants who are hospitalised with bronchiolits. We are partnering leaders in the United Kingdom in this study which will examine whether boosting the immune system by giving granules of lysed dead bacteria can prevent future childhood asthma.
GO ID:
GO Title:
MRFF Clinical Trial Activity Initiative - 2020 International Clinical Trial Collaborations Grant Opportunity
Internal Reference ID:
MRF2005981
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Queensland University of Technology
Recipient ABN:
83 791 724 622
Grant Recipient Location
Suburb:
Brisbane City
Town/City:
Brisbane City
Postcode:
4000
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, QLD, NT, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED KINGDOM